Prot #IM101-344: A Phase II Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis—A Double-Blind, Placebo-Controlled, Randomized Controlled Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date4/21/1610/31/17

Funding

  • University of Michigan (Prot #IM101-344)
  • Bristol-Myers Squibb Company (Prot #IM101-344)